A unified model for apical caspase activation

Molecular Cell

Volumn 11, Issue 2, 2003, Pages 529-541

  Boatright, Kelly M ^a   Renatus, Martin ^e   Scott, Fiona L ^e   Sperandio, Sabina ^e   Shin, Hwain ^a   Pedersen, Irene M ^e   Ricci, Jean Ehrland ^b   Edris, Wade A ^c   Sutherlin, Daniel P ^d   Green, Douglas R ^b   Salvesen, Guy S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c Wyeth Ayerst Research   (United States)

^d GENENTECH INC   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 8; CASPASE 9; ENZYME PRECURSOR; MONOMER;

APOPTOSIS; ARTICLE; DIMERIZATION; ENZYME ACTIVATION; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN STRUCTURE;

MAMMALIA;

EID: 0037291871     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00051-0     Document Type: Article

References (56)

1. Acehan D., Jiang X., Morgan D.G., Heuser J.E., Wang X., Akey C.W. Three-dimensional structure of the apoptosome. implications for assembly, procaspase-9 binding and activation Mol. Cell. 9:2002;423-432.
2. Ashkenazi A., Dixit V.M. Death receptors. signaling and modulation Science. 281:1998;1305-1308.
3. 2-macroglobulin molecule. Biochem. J. 181:1979;401-418.
4. Blanchard H., Kodandapani L., Mittl P.R.E., Di Marco S., Krebs J.F., Wu J.C., Tomaselli K.J., Grütter M.G. The three-dimensional structure of caspase-8. an initiator enzyme in apoptosis Structure. 27:1999;1125-1133.
5. Bose K., Clark A.C. Dimeric procaspase-3 unfolds via a four-state equilibrium process. Biochemistry. 40:2001;14236-14242.
6. Bury A. Analysis of protein and peptide mixtures. Evaluation of three sodium dodecyl sulphate-polyacrylamide gel electrophoresis buffer systems J. Chromatogr. 213:1981;491-500.
7. Chai J., Shiozaki E., Srinivasula S.M., Wu Q., Dataa P., Alnemri E.S., Shi Y. Structural basis of caspase-7 inhibition by XIAP. Cell. 104:2001;769-780. a.
8. Chai J., Wu Q., Shiozaki E., Srinivasula S.M., Alnemri E.S., Shi Y. Crystal structure of a procaspase-7 zymogen. mechanisms of activation and substrate binding Cell. 107:2001;399-407. b.
9. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., Peter M.E., Yang X. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21:2002;3704-3714.
10. Chun H.J., Zheng L., Ahmad M., Wang J., Speirs C.K., Siegel R.M., Dale J.K., Puck J., Davis J., Hall C.G.et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature. 419:2002;395-399.
11. Cowling V., Downward J. Caspase-6 is the direct activator of caspase-8 in the cytochrome c- induced apoptosis pathway. absolute requirement for removal of caspase-6 prodomain Cell Death Differ. 9:2002;1046-1056.
12. Deveraux Q., Takahashi R., Salvesen G.S., Reed J.C. X-linked IAP is a direct inhibitor of cell death proteases. Nature. 388:1997;300-304.
13. Deveraux Q.L., Leo E., Stennicke H.R., Welsh K., Salvesen G.S., Reed J.C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 18:1999;5242-5251.
14. Donepudi M., Mac Sweeney A., Briand C., Gruetter M.G. Insights into the regulatory mechanism for caspase-8 activation. Mol. Cell. 11:2003;543-549. this issue,
15. Duan H., Orth K., Chinnaiyan A.M., Poirier G.G., Froelich C.J., He W.-W., Dixit V.M. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271:1996;16720-16724.
16. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases. structure, activation, substrates, and functions during apoptosis Annu. Rev. Biochem. 68:1999;383-424.
17. Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry. 6:1967;1948-1954.
18. Ekert P.G., Silke J., Vaux D.L. Caspase inhibitors. Cell Death Differ. 6:1999;1081-1086.
19. Fernandes-Alnemri T., Armstrong R., Krebs J., Srinivasula S.M., Wang L., Bullrich F., Fritz L., Trapani J.A., Croce C.M., Tomaselli K.J.et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA. 93:1996;7464-7469.
20. Fesik S.W. Insights into programmed cell death through structural biology. Cell. 103:2000;273-282.
21. Goltsev Y.V., Kovalenko A.V., Arnold E., Varfolomeev E.E., Brodianskii V.M., Wallach D. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272:1997;19641-19644.
22. L and initiates cell death. Proc. Natl. Acad. Sci. USA. 94:1997;11333-11338.
23. Inohara N., Koseki T., Hu Y., Chen S., Nunez G. CLARP, a death effector domain containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;10717-10722.
24. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
25. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
26. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
27. Mallet V.O., Mitchell C., Guidotti J.E., Jaffray P., Fabre M., Spencer D., Arnoult D., Kahn A., Gilgenkrantz H. Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice. Nat. Biotechnol. 20:2002;1234-1239.
28. Martinon F., Burns K., Tschopp J. The inflammasome. a molecular platform triggering activation of inflammatory caspases and processing of proIL-β Mol. Cell. 10:2002;417-426.
29. Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D.W., Briand C., Grutter M.G. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277:2002;45162-45171.
30. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R.et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:1996;817-827.
31. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273:1998;2926-2930.
32. Renatus M., Stennicke H.R., Scott F.L., Liddington R.C., Salvesen G.S. Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. USA. 98:2001;14250-14255.
33. Riedl S.J., Fuentes-Prior P., Renatus M., Kairies N., Krapp R., Huber R., Salvesen G.S., Bode W. Structural basis for the activation of human procaspase-7. Proc. Natl. Acad. Sci. USA. 98:2001;14790-14795. a.
34. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun S., Fesik S.W., Liddington R.C., Salvesen G.S. Structural basis for the inhibition of caspase-3 by XIAP. Cell. 104:2001;791-800. b.
35. Rodriguez J., Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 13:1999;3179-3184.
36. Salvesen G.S., Dixit V.M. Caspases. intracellular signaling by proteolysis Cell. 91:1997;443-446.
37. Salvesen G.S., Dixit V.M. Caspase activation. the induced-proximity model Proc. Natl. Acad. Sci. USA. 96:1999;10964-10967.
38. Schmidt U., Darke P.L. Dimerization and activation of the herpes simplex virus type 1 protease. J. Biol. Chem. 272:1997;7732-7735.
39. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell. 9:2002;459-470.
40. Shu H.B., Halpin D.R., Goeddel D.V. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity. 6:1997;751-763.
41. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S.et al. Ordering the cytochrome c-initiated caspase cascade. hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner J. Cell Biol. 144:1999;281-292.
42. Srinivasula S.M., Hegde R., Saleh A., Datta P., Shiozaki E., Chai J., Lee R.A., Robbins P.D., Fernandes-Alnemri T., Shi Y., Alnemri E.S. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature. 410:2001;112-116.
43. Srinivasula S.M., Poyet J.L., Razmara M., Datta P., Zhang Z., Alnemri E.S. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 277:2002;21119-21122.
44. Stennicke H.R., Salvesen G.S. Caspases. preparation and characterization Methods. 17:1999;313-319.
45. Stennicke H.R., Deveraux Q.L., Humke E.W., Reed J.C., Dixit V.M., Salvesen G.S. Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 274:1999;8359-8362.
46. Stennicke H.R., Jurgensmeier J.M., Shin H., Deveraux Q., Wolf B.B., Yang X., Zhou Q., Ellerby H.M., Ellerby L.M., Bredesen D.et al. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273:1998;27084-27090.
47. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., Ellerby L.M., Bredesen D., Freeze H., Abrahamson M.et al. Lysosomal protease pathways to apoptosis. cleavage of bid, not pro-caspases, is the most likely route J. Biol. Chem. 276:2001;3149-3157.
48. Sun C., Cai M., Meadows R.P., Xu N., Gunasekera A.H., Herrmann J., Wu J.C., Fesik S.W. NMR structure and mutagenesis of the third BIR domain of the inhibitor of apoptosis protein XIAP. J. Biol. Chem. 275:2000;33777-33781.
49. Talanian R.V., Yang X., Turbov J., Seth P., Ghayur T., Casiano C.A., Orth K., Froelich C.J. Granule-mediated killing. pathways for granzyme B-initiated apoptosis J. Exp. Med. 186:1997;1323-1331.
50. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M. Yama/CPP32-β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
51. Thornberry N.A., Lazebnik Y. Caspases. enemies within Science. 281:1998;1312-1316.
52. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P.et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:1997;17907-17911.
53. Tschopp J., Irmler M., Thome M. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10:1998;552-558.
54. Wang J., Lenardo M.J. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J. Cell Sci. 113:2000;753-757.
55. Watt W., Koeplinger K.A., Mildner A.M., Heinrikson R.L., Tomasselli G., Watenpaugh K.D. The atomic resolution structure of human caspase-8, a key activator of apoptosis. Structure. 27:1999;1135-1143.
56. Zhou Q., Salvesen G.S. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem. J. 324:1997;361-364.